During the past decade, Nemocnice Jihlava prispevkova organizace conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nemocnice Jihlava prispevkova organizace" are "Multiple Sclerosis" (2 trials), "Central Neuropathic Pain" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Nemocnice Jihlava prispevkova organizace" in a lesser frequency.

Most popular intervention types in "Nemocnice Jihlava prispevkova organizace" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AVP-923-20" (1 trials), "AVP-923-30" (1 trials), "AVP-923-45" (1 trials), "Interferon beta-1a" (1 trials) and "Ozanimod" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Jihlava prispevkova organizace" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Jihlava prispevkova organizace". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nemocnice Jihlava prispevkova organizace, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Jihlava prispevkova organizace, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".